Richard C. Becker

Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

Udaya S. Tantry, Laurent Bonello, Dániel Aradi et al. · Journal of the American College of Cardiology · 2013 · 892 citations

Thrombopoiesis, Thrombosis, Cardiovascular Disease +12

Platelet Inhibition with Cangrelor in Patients Undergoing PCI

Robert A. Harrington, Gregg W. Stone, Steven E. McNulty et al. · New England Journal of Medicine · 2009 · 613 citations · Full text

Seasonal Distribution of Acute Myocardial Infarction in the Second National Registry of Myocardial Infarction 11The National Registry of Myocardial Infarction is supported by Genentech, Inc., South San Francisco, California. Genentech, Inc. reimburses ClinTrials Research, Inc. for the cost of data analysis and biostatistical services.

Frederick A. Spencer, Robert J. Goldberg, Richard C. Becker et al. · Journal of the American College of Cardiology · 1998 · 482 citations

Cardiovascular Epidemiology, Cardiovascular Disease, Atherosclerosis +12

Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome

John H. Alexander, Richard C. Becker, Deepak L. Bhatt et al. · Circulation · 2009 · 460 citations · Full text

Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study

Richard C. Becker, David J. Moliterno, Lisa K. Jennings et al. · The Lancet · 2009 · 295 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Coronary Artery Disease +9